Venus Remedies

VENUSREM25 Apr 2024
Pharmaceuticals
₹
+1.20 (+0.36%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Venus Remedies
Venus Remedies
Pharmaceuticals
VENUSREM25 Apr 2024
₹
+1.20 (+0.36%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Venus Remedies - Share Price & Details

Lowest Today
327.4
Highest Today
333.75
Today’s Open
330.7
Prev. Close
330
52 Week High
429.6
52 Week Low
185.65
Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
66.67%
Upper Circuit
Lower Circuit
P/E TTM
17.29
P/B Ratio
0.90
Traded Value(Cr)
0.00
EPS TTM
19.09
Book value
Dividend
0.00%

Price Performance

-1.40 %
1 Wk
6.19 %
1 M
-12.44 %
3 M
66.67 %
1 Y
-18.64 %
YTD

Traded Volume Movement

Technical Details

Support 3
321
Support 2
324
Support 1
328
Pivot Point :
331
Resistance 1
335
Resistance 2
338
Resistance 3
341

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Venus Remedies Ltd
₹331.20(+1.20/0.36%)
331.20+1.20441.1166.6717.290.90
Astrazeneca Pharma India Ltd
₹5,315.05(+45.75/0.87%)
5,315.05+45.7513,173.2567.2782.5920.11
Cipla Ltd
₹1,395.50(-3.30/-0.24%)
1,395.50-3.30112,938.4154.9134.344.36
Bliss GVS Pharma Ltd
₹117.45(+1.80/1.56%)
117.45+1.801,210.7548.8417.741.24
Abbott India Ltd
₹25,249.50(-212.70/-0.84%)
25,249.50-212.7054,107.1813.0347.2317.40
Amrutanjan Health Care Ltd
₹692.95(+13.20/1.94%)
692.95+13.201,965.2012.7144.667.50

About Venus Remedies Ltd

Venus Remedies Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 441.11 crores. It has reported a sales of Rs. 131.23 crores and a net profit of Rs. 8.19 crores for the quarter ended December 2018. The company management includes Pawan Chaudhary, Pawan Chaudhary,Manu Chaudhary,Peeyush Jain,Ashutosh Jain,Gilbert Wenzel,S. K. Chadha,Neha Kodan,Navdeep Sud,Savita Gupta,Akshansh Chaudhary,Nps Monga (Venus Remedies Ltd) among others.
Chairman
Pawan Chaudhary
Registered office
S C No 857 Cabin No 10 2nd Flr,N A C Manimajra,Chandigarh,Chandigarh,160101
FAX :
Background
Incorporation Year1989
Face Value₹10
Market Lot1

Latest News

📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
Nestle India announces dividend of Rs 8.50 per share. Check record date
Maggi-maker Nestle India on Thursday announced a dividend of Rs 8.50 per share while releasing its March quarter financial numbers. The MNC FMCG firm has fixed July 15 as the record date for determining shareholder eligibility while the payment would be done on August 2.“The Board of Directors have recommended a final dividend for the fifteen months financial year ended 31 March 2024.
25 Apr 2024 | 12:58 PM
Hot Stocks: Brokerage view on Dalmia Bharat, Axis Bank, Kotak Bank
Global brokerage Morgan Stanley maintained an overweight rating on Dalmia Bharat, Macquarie recommended an outperform rating on Axis Bank.📌Morgan Stanley on Dalmia Bharat: Overweight| Target Rs 2450.  📌Macquarie on Axis Bank: Outperform| Target Rs 1300. 📌Jefferies on Kotak Mahindra Bank: Hold| Target Rs 1970. 📌Investec on Aurobindo Pharma: Buy| Target Rs 1350.
25 Apr 2024 | 12:51 PM
HUL shares slip on lower than expected Q4 revenue and margin growth
Hindustan Unilever's share price experienced a decline of over a percent on Thursday following the release of its earnings report for the quarter ended March 2024. HUL shares dropped by as much as 1.2% to Rs 2,218.00 apiece on the BSE, reflecting subdued Q4 results. FMCG major Hindustan Unilever (HUL) reported a standalone net profit of Rs 2,406 crore in Q4FY24, marking a decline of 6%.
25 Apr 2024 | 12:45 PM
view more news

How to buy Venus Remedies shares on nse?

To buy Venus Remedies shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Venus Remedies share price today?

The Venus Remedies shares price on nse is Rs.331.2 today.

What is the market cap of Venus Remedies shares on BSE ?

The company has a market capitalization of Rs.441.11Cr

What is the PE & PB ratio of Venus Remedies shares ?

PE is 17.29 and PB is 0.9

What is the 52 Week High and Low of Venus Remedies shares?

Venus Remedies stock price high: Rs.429.6 Venus Remedies stock price low: Rs.185.65
BUY
SELL